Back to Main

Faculty Detail    
Name DANA VICTOR RIZK
 
Campus Address ZRB 629 Zip 0007
Phone 205-934-9509
E-mail drizk@uab.edu
Other websites
      ICM Preceptor


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Medicine  Med - Nephrology Associate Professor
Center  General Clinical Research Center  Ctr for Clinical & Translational Sci Associate Professor

Biographical Sketch 
POST DOCTORAL TRAINING:
2003-2004 Nephrology Fellow Emory University Hospital
2002-2003 Medicine Chief resident Emory University Hospital
2001-2002 Nephrology fellow Emory University Hospital
2000-2001 Internal Medicine Resident (PGY-3) Emory University Hospital
1998-2000 Internal Medicine Resident (PGY-1/2) St Louis University Hospital
1997-1998 Internal Medicine Resident (PGY-1) American University of Beirut

ACADEMIC/HOSPITAL APPOINTMENTS:

2010-present: Director of the Chronic Kidney Disease clinic at the Kirklin clinic.
2008-present: Director of Davita East Dialysis Unit
2012-present: Associate Professor of Medicine University of Alabama at Birmingham
2008-2012: Assistant Professor of Medicine University of Alabama at Birmingham
2006-2008: Assistant Professor of Medicine Emory University
2004-2005: Instructor of Medicine Emory University

HONORS/AWARDS:
2010: Outstanding Division Teacher in Nephrology from the UAB department of Medicine
2005-2006: Emory University Golden Apple Award for excellence in teaching
2004: Outstanding Presentation Award at the National Kidney Foundation Meeting, Georgia Chapter Sea Island GA
2003: Recipient of Certificate of Appreciation for Outstanding Contribution to the Education of PA students. Department of Family and Preventive Medicine, Emory University


Society Memberships
Organization Name Position Held Org Link
American Society of Nephrology  Member   
Medical Review Borad for ESRD Network 8  Co-Chair   
National Kidney Foundation  Member   
Southern Society of Clinical Investigation  Member elect   
Task Force for NKF Nephrology and Transplant Update (GA and AL chapter)  Member   

Research/Clinical Interest
Title
1-Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
Description
Dr Rizk's main research interests revolve around all aspects of chronic kidney disease. This includes exploring new avenues for the successful delivery of health information to patients with chronic kidney disease (CKD). It also includes identifying new and potentially modifiable risk factors for cardiovascular outcomes. Dr Rizk's research carrier started with autosomal dominant polycystic kidney disease (PKD) and she continues to see and care for patients with PKD in a dedicated clinic.

Selected Publications 
Publication PUBMEDID
Gutiérrez OM, Judd SE, Muntner P, Rizk DV, McClellan WM, Safford MM, Cushman M, Kissela BM, Howard VJ, Warnock DG.
Racial differences in albuminuria, kidney function, and risk of stroke.Neurology. 2012 Oct 16;79(16):1686-92. 
22993285 
Zuber K, Davis J, Rizk D. Kidney Disease Education One Year After the Medicare Improvement of Patients and Providers Act: A Survey of the US Nephrology Practices. Am J Kidney Dis. 2012 Jun;59(6):892-4  22464878 
Rizk DV, Gutierrez O, Levitan EB, McClellan WM, Safford M, Soliman EZ, Warnock DG, Muntner P. Prevalence and Prognosis of Unrecognized Myocardial Infarctions in Chronic Kidney Disease. Nephrol Dial Transplant. 2012 Sep;27(9):3482-8.
 
22167594 
Muntner P, Bowling CB, Gao L, Rizk D, Judd S, Tanner RM, McClellan W, Warnock DG. Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2200-7  21737849 
Rizk DV, Warnock DG. Warfarin-related nephropathy: another newly recognized complication of an old drug. Kidney Int. 2011 Jul; 80(2):131-3  21720303 
Dana Rizk, Claudine Jurkovitz, Emir Veledar,Susan Bagby,Deborah A.Baumgarten, Frederic Rahbari-Oskoui, Theodore Steinman, and Arlene B. Chapman. Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients not yet on Dialysis. Clin J Am Soc Nephrol 4:560-566,2009  19261830 
Badero OJ, Schlanger L, RizkD. Gadolinium nephrotoxicity: case report of a rare entity and review of the literature Clin Nephrol.2008Dec;70(6):518-22  19049710 
D Rizk MD; AB Chapman MD. Treatment of ADPKD: The New Horizon for children with ADPKD. Pediatr Nephrol. 2008 Jul;23(7):1029-36. Epub 2008 Feb 8. Review  18259779 
Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Rizk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance measurements of renal blood flow and disease progreesion in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20  17699395 
Arlene Chapman MD, Frederic Rahbari-Oskoui MD, Stine Errboe BMSc and Dana Rizk MD. Hypertension in Autosomal Dominant Polycystic Kidney Disease. US Nephrology, 2010;5(1):54-9   
D Rizk MD; AB Chapman MD. Inherited Cystic Kidney Diseases. Chapter for the “Primer in Kidney Diseases”, 2006.   

Keywords
health literacy, cardiovascular outcomes, chronic kidney disease, polycystic kidney disease